In 2012, PrEPFacts.org became the first informational PrEP resource online. The creation of the site and accompanying informational materials was a collaboration of San Francisco AIDS Foundation, San Francisco Department of Public Health, Project Inform, Be The Generation, Gilead Sciences and other local health agencies, community-based providers, and PrEP advocates.
PrEP, which stands for pre-exposure prophylaxis, is an effective way to prevent HIV that involves taking medication either daily or around the times you have sex. If you’re new to PrEP or want to learn more about who it’s for, how to access it, the research supporting it and how effective it is, check out PrEPFacts.org to learn more.
PrEPfacts.org answers your questions about research, best practices for staying healthy, where to get a prescription and more. Visit PrEPfacts.org to learn more.
We’ve also made PrEPfacts.org campaign materials available for download in the virtual asset library. Providers all over the country have used these materials in their own clinics to share education about the effectiveness of PrEP.
Cabotegravir for PrEP: Resistance, infections & more explained
We turned to Janessa Broussard, RN, MSN, AGNP-C, to shed some light on the science behind this exciting new therapy, and offer a perspective on breakthrough infections and resistance mutations.
Injectable PrEP Offers a New Option for Women
A recent study reveals that injectable cabotegravir could be an effective HIV prevention option for cisgender women.
Does PrEP work for trans people taking gender-affirming hormones? Yes, says new research
People taking gender-affirming hormones may use PrEP with confidence, said Robert M. Grant, MD, MPH.
“Tremendously exciting” news of cabotegravir long-acting injectable for PrEP shared at AIDS 2020
Final results of the HPTN 083 study show that for men who have sex with men and transgender women, a cabotegravir injection provided highly effective HIV prevention when given once every two months.
High effectiveness and adherence to PrEP 2-1-1 in large San Francisco AIDS Foundation study
At AIDS 2020, San Francisco AIDS Foundation presented positive findings from one of the largest pre-exposure prophylaxis (PrEP) 2-1-1 adherence and effectiveness studies to date.
How to afford PrEP and HIV meds if you lose health insurance
There are a variety of free programs that can help people afford medications and care even if they don’t have insurance. Read on for advice from Reina Hernandez, a PrEP benefits and HIV linkage manager from San Francisco
PrEP injectable found to be “highly effective” for HIV prevention in HPTN study
Long-acting cabotegravir injections, given once every other month, were as effective at preventing HIV as daily oral Truvada.
¿Debes seguir PrEP si te estás poniendo en cuarentena?
Nuestro equipo de PrEP recomienda seguir con tu rutina de PrEP, aunque no estés teniendo encuentros sexuales con nadie ahora mismo. Consigue apoyo de nosotros si lo necesitas.